Deitelzweig S - Search Results

1

Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach.

Li X, Keshishian A, Hamilton M, Horblyuk R, Gupta K, Luo X, Mardekian J, Friend K, Nadkarni A, Pan X, Lip GYH, Deitelzweig S. Li X, et al. Among authors: deitelzweig s. PLoS One. 2018 Jan 26;13(1):e0191722. doi: 10.1371/journal.pone.0191722. eCollection 2018. PLoS One. 2018. PMID: 29373602 Free PMC article.

2

Warfarin therapy in patients with venous thromboembolism: patterns of use and predictors of clinical outcomes.

Deitelzweig SB, Lin J, Kreilick C, Hussein M, Battleman D. Deitelzweig SB, et al. Adv Ther. 2010 Sep;27(9):623-33. doi: 10.1007/s12325-010-0056-z. Epub 2010 Jul 30. Adv Ther. 2010. PMID: 20680533

3

Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials.

Deitelzweig S, Amin A, Jing Y, Makenbaeva D, Wiederkehr D, Lin J, Graham J. Deitelzweig S, et al. J Med Econ. 2012;15(4):776-85. doi: 10.3111/13696998.2012.680555. Epub 2012 Apr 13. J Med Econ. 2012. PMID: 22449118 Free article.

4

Evaluation of incremental healthcare resource burden and readmission rates associated with hospitalized hyponatremic patients in the US.

Amin A, Deitelzweig S, Christian R, Friend K, Lin J, Belk K, Baumer D, Lowe TJ. Amin A, et al. Among authors: deitelzweig s. J Hosp Med. 2012 Oct;7(8):634-9. doi: 10.1002/jhm.1973. Epub 2012 Sep 7. J Hosp Med. 2012. PMID: 22961813

5

Hyponatremia-associated healthcare burden among US patients hospitalized for cirrhosis.

Deitelzweig S, Amin A, Christian R, Friend K, Lin J, Lowe TJ. Deitelzweig S, et al. Adv Ther. 2013 Jan;30(1):71-80. doi: 10.1007/s12325-012-0073-1. Epub 2012 Dec 21. Adv Ther. 2013. PMID: 23292659

6

Transitions of care in anticoagulation management for patients with atrial fibrillation.

Deitelzweig SB. Deitelzweig SB. Hosp Pract (1995). 2012 Oct;40(4):20-7. doi: 10.3810/hp.2012.10.999. Hosp Pract (1995). 2012. PMID: 23299032

7

Healthcare resource burden associated with hyponatremia among patients hospitalized for heart failure in the US.

Amin A, Deitelzweig S, Christian R, Friend K, Lin J, Lowe TJ. Amin A, et al. Among authors: deitelzweig s. J Med Econ. 2013;16(3):415-20. doi: 10.3111/13696998.2013.766615. Epub 2013 Jan 23. J Med Econ. 2013. PMID: 23336297 Free article.

8

Health care utilization, costs, and readmission rates associated with hyponatremia.

Deitelzweig S, Amin A, Christian R, Friend K, Lin J, Lowe TJ. Deitelzweig S, et al. Hosp Pract (1995). 2013 Feb;41(1):89-95. doi: 10.3810/hp.2013.02.1014. Hosp Pract (1995). 2013. PMID: 23466971

9

Warfarin use and stroke risk among patients with nonvalvular atrial fibrillation in a large managed care population.

Deitelzweig SB, Buysman E, Pinsky B, Lacey M, Jing Y, Wiederkehr D, Graham J. Deitelzweig SB, et al. Clin Ther. 2013 Aug;35(8):1201-10. doi: 10.1016/j.clinthera.2013.06.005. Epub 2013 Jul 16. Clin Ther. 2013. PMID: 23867114

10

Medical costs in the US of clinical events associated with oral anticoagulant (OAC) use compared to warfarin among non-valvular atrial fibrillation patients ≥75 and <75 years of age, based on the ARISTOTLE, RE-LY, and ROCKET-AF trials.

Deitelzweig S, Amin A, Jing Y, Makenbaeva D, Wiederkehr D, Lin J, Graham J. Deitelzweig S, et al. J Med Econ. 2013 Sep;16(9):1163-8. doi: 10.3111/13696998.2013.826664. Epub 2013 Aug 8. J Med Econ. 2013. PMID: 23869941 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters